Latest News about MRK
Recent news which mentions MRK
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
Britain Approves First Oral COVID-19 Antiviral From Merck
November 04, 2021
Tickers
MRK
From Benzinga
Is There Any Hope for Atea Pharmaceuticals Stock?
November 04, 2021
From Motley Fool
Moderna’s Outlook Is Directly Tied to the Eventual Receding of Covid-19
November 03, 2021
From InvestorPlace
7 Best Stocks to Buy Now If You Have Faith in These Analyst Upgrades
November 03, 2021
From InvestorPlace
Evpandpresident And Merck Animal Heallth Of Merck & Co Trades $11M In Company Stock
November 03, 2021
Tickers
MRK
From Benzinga
3 Explosive Biotech Stocks -- Could They Shoot Even Higher?
November 03, 2021
From Motley Fool
Here's How Much Extra Money Pfizer Will Make From Vaccines for Younger Kids This Year
November 02, 2021
From Motley Fool
ANI Pharma's Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates
November 01, 2021
From Benzinga
Merck Pushes Acceleron Buyout By Refiling For Antitrust Review
November 01, 2021
From Benzinga
Merck Dives Further Into Cytokine Research With Synthekine Deal
November 01, 2021
Tickers
MRK
From Benzinga
Pasithea and Evotec Team Up — Attempt to Make Headway on Brain Disorders
November 01, 2021
From Benzinga
2 Best Biotech Stocks to Buy in November
November 01, 2021
From Motley Fool
From Benzinga
Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone
November 01, 2021
From InvestorPlace
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
2 Growth Stocks That Could Deliver 1,000% Returns
October 31, 2021
From Motley Fool
3 Top Dividend Stocks to Buy in November
October 31, 2021
From Motley Fool
3 Biotech Stocks That Could Make You Richer
October 30, 2021
From Motley Fool
Why Xeris Pharmaceuticals Is Soaring 7% Higher Today
October 29, 2021
From Motley Fool
CDC says people with mental health issues should get COVID-19 vaccine boosters, as U.S. vaccination rate remains stubbornly static
October 29, 2021
From MarketWatch
Novavax Just Caught a Big Break
October 29, 2021
From InvestorPlace
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
From Benzinga
From Benzinga
How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market
October 29, 2021
From Motley Fool
Cheap Antidepressant Fluvoxamine Shows Potential In Reducing COVID-19 Hospitalization
October 28, 2021
Tickers
MRK
From Benzinga
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.